Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer’s Disease?

Rockwood, K. (2011). Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?. International Journal of Alzheimer＇s Disease, 2011(), 775-778. https://doi.org/10.4061/2011/598175
Mattsson, N., Zetterberg, H., & Blennow, K. (2010). Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2010(), 309-313. https://doi.org/10.4061/2010/610613
Anoop, A., Singh, P. K., Jacob, R. S., & Maji, S. K. (2010). CSF Biomarkers for Alzheimer's Disease Diagnosis. International Journal of Alzheimer＇s Disease, 2010(), 296-307. https://doi.org/10.4061/2010/606802
Leyhe, T., Shori, T. D., Laske, C., Mielke, M. M., & Maetzler, W. (2013). Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia. International Journal of Alzheimer＇s Disease, 2013(), 85-86. https://doi.org/10.1155/2013/473181
Nacmias, B., Reitz, C., & Arendt, T. (2011). Early Clinical and Molecular Detection of Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2011(), 1085-1085. https://doi.org/10.4061/2011/818639